Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1990 Dec;66(782):1010–1024. doi: 10.1136/pgmj.66.782.1010

Diabetes mellitus.

A B Johnson 1, R Taylor 1
PMCID: PMC2429784  PMID: 2084646

Full text

PDF
1010

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sakkaf L., Pozzilli P., Tarn A. C., Schwarz G., Gale E. A., Bottazzo G. F. Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes. Diabetologia. 1989 May;32(5):322–325. doi: 10.1007/BF00265550. [DOI] [PubMed] [Google Scholar]
  2. Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y., Okuyama M., Juji T. High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes. 1990 Feb;39(2):266–269. doi: 10.2337/diab.39.2.266. [DOI] [PubMed] [Google Scholar]
  3. Bak J. F., Jacobsen U. K., Jørgensen F. S., Pedersen O. Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training. J Clin Endocrinol Metab. 1989 Jul;69(1):158–164. doi: 10.1210/jcem-69-1-158. [DOI] [PubMed] [Google Scholar]
  4. Bak J. F., Schmitz O., Sørensen N. S., Pedersen O. Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients. Diabetes. 1989 Nov;38(11):1343–1350. [PubMed] [Google Scholar]
  5. Bell G. I., Kayano T., Buse J. B., Burant C. F., Takeda J., Lin D., Fukumoto H., Seino S. Molecular biology of mammalian glucose transporters. Diabetes Care. 1990 Mar;13(3):198–208. doi: 10.2337/diacare.13.3.198. [DOI] [PubMed] [Google Scholar]
  6. Benzi L., Trischitta V., Ciccarone A., Cecchetti P., Brunetti A., Squatrito S., Marchetti P., Vigneri R., Navalesi R. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients. Diabetes. 1990 Jul;39(7):844–849. doi: 10.2337/diab.39.7.844. [DOI] [PubMed] [Google Scholar]
  7. Bevilacqua S., Buzzigoli G., Bonadonna R., Brandi L. S., Oleggini M., Boni C., Geloni M., Ferrannini E. Operation of Randle's cycle in patients with NIDDM. Diabetes. 1990 Mar;39(3):383–389. doi: 10.2337/diab.39.3.383. [DOI] [PubMed] [Google Scholar]
  8. Bild D. E., Selby J. V., Sinnock P., Browner W. S., Braveman P., Showstack J. A. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care. 1989 Jan;12(1):24–31. doi: 10.2337/diacare.12.1.24. [DOI] [PubMed] [Google Scholar]
  9. Bingley P. J., Gale E. A. Rising incidence of IDDM in Europe. Diabetes Care. 1989 Apr;12(4):289–295. doi: 10.2337/diacare.12.4.289. [DOI] [PubMed] [Google Scholar]
  10. Blackshear P. J., Roussell A. M., Cohen A. M., Nathan D. M. Basal-rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes. A prospective crossover trial. Diabetes Care. 1989 Jul-Aug;12(7):455–463. doi: 10.2337/diacare.12.7.455. [DOI] [PubMed] [Google Scholar]
  11. Bleich D., Jackson R. A., Soeldner J. S., Eisenbarth G. S. Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes. Diabetes Care. 1990 Feb;13(2):111–118. doi: 10.2337/diacare.13.2.111. [DOI] [PubMed] [Google Scholar]
  12. Bonadonna R. C., Zych K., Boni C., Ferrannini E., DeFronzo R. A. Time dependence of the interaction between lipid and glucose in humans. Am J Physiol. 1989 Jul;257(1 Pt 1):E49–E56. doi: 10.1152/ajpendo.1989.257.1.E49. [DOI] [PubMed] [Google Scholar]
  13. Borssén B., Lithner F. Plaster casts in the management of advanced ischaemic and neuropathic diabetic foot lesions. Diabet Med. 1989 Nov;6(8):720–723. doi: 10.1111/j.1464-5491.1989.tb01264.x. [DOI] [PubMed] [Google Scholar]
  14. Brand F. N., Abbott R. D., Kannel W. B. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes. 1989 Apr;38(4):504–509. doi: 10.2337/diab.38.4.504. [DOI] [PubMed] [Google Scholar]
  15. Brillon D. J., Freidenberg G. R., Henry R. R., Olefsky J. M. Mechanism of defective insulin-receptor kinase activity in NIDDM. Evidence for two receptor populations. Diabetes. 1989 Mar;38(3):397–403. doi: 10.2337/diab.38.3.397. [DOI] [PubMed] [Google Scholar]
  16. Brons I. G., Calne R. Y., Jamieson N. V., Rolles K., Williams P. F., Evans D. B. Results with combined kidney and paratopic segmental-pancreas transplantation. Diabetes. 1989 Jan;38 (Suppl 1):18–20. doi: 10.2337/diab.38.1.s18. [DOI] [PubMed] [Google Scholar]
  17. Bruce D. G., Chisholm D. J., Storlien L. H., Kraegen E. W. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes. 1988 Jun;37(6):736–744. doi: 10.2337/diab.37.6.736. [DOI] [PubMed] [Google Scholar]
  18. Bruining G. J., Molenaar J. L., Grobbee D. E., Hofman A., Scheffer G. J., Bruining H. A., de Bruyn A. M., Valkenburg H. A. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet. 1989 May 20;1(8647):1100–1103. doi: 10.1016/s0140-6736(89)92383-0. [DOI] [PubMed] [Google Scholar]
  19. Butler P. C., Chou J., Carter W. B., Wang Y. N., Bu B. H., Chang D., Chang J. K., Rizza R. A. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes. 1990 Jun;39(6):752–756. doi: 10.2337/diab.39.6.752. [DOI] [PubMed] [Google Scholar]
  20. Cama A., Patterson A. P., Kadowaki T., Kadowaki H., Siegel G., D'Ambrosio D., Lillioja S., Roth J., Taylor S. I. The amino acid sequence of the insulin receptor is normal in an insulin-resistant Pima Indian. J Clin Endocrinol Metab. 1990 Apr;70(4):1155–1161. doi: 10.1210/jcem-70-4-1155. [DOI] [PubMed] [Google Scholar]
  21. Carpentier J. L. The cell biology of the insulin receptor. Diabetologia. 1989 Sep;32(9):627–635. doi: 10.1007/BF00274248. [DOI] [PubMed] [Google Scholar]
  22. Clark A. Islet amyloid and type 2 diabetes. Diabet Med. 1989 Sep-Oct;6(7):561–567. doi: 10.1111/j.1464-5491.1989.tb01228.x. [DOI] [PubMed] [Google Scholar]
  23. Cook J. J., Hudson I., Harrison L. C., Dean B., Colman P. G., Werther G. A., Warne G. L., Court J. M. Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes. 1989 Jun;38(6):779–783. doi: 10.2337/diab.38.6.779. [DOI] [PubMed] [Google Scholar]
  24. D'Antonio J. A., Ellis D., Doft B. H., Becker D. J., Drash A. L., Kuller L. H., Orchard T. J. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM. Diabetes Care. 1989 Nov-Dec;12(10):694–670. doi: 10.2337/diacare.12.10.694. [DOI] [PubMed] [Google Scholar]
  25. Dyck P. J., O'Brien P. C. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care. 1989 Oct;12(9):649–652. doi: 10.2337/diacare.12.9.649. [DOI] [PubMed] [Google Scholar]
  26. Eadington D. W., Frier B. M. Type 1 diabetes and driving experience: an eight-year cohort study. Diabet Med. 1989 Mar;6(2):137–141. doi: 10.1111/j.1464-5491.1989.tb02101.x. [DOI] [PubMed] [Google Scholar]
  27. Eriksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widén E., Schalin C., Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989 Aug 10;321(6):337–343. doi: 10.1056/NEJM198908103210601. [DOI] [PubMed] [Google Scholar]
  28. Felley C. P., Felley E. M., van Melle G. D., Frascarolo P., Jéquier E., Felber J. P. Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia. Am J Physiol. 1989 Jun;256(6 Pt 1):E747–E752. doi: 10.1152/ajpendo.1989.256.6.E747. [DOI] [PubMed] [Google Scholar]
  29. Ferris F. L., 3rd, Podgor M. J., Davis M. D. Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12. Ophthalmology. 1987 Jul;94(7):754–760. doi: 10.1016/s0161-6420(87)33526-2. [DOI] [PubMed] [Google Scholar]
  30. Fisher B. M., Frier B. M. Usefulness of cardiovascular tests of autonomic function in asymptomatic diabetic patients. Diabetes Res Clin Pract. 1989 Feb 15;6(2):157–160. doi: 10.1016/0168-8227(89)90121-6. [DOI] [PubMed] [Google Scholar]
  31. Garvey W. T., Huecksteadt T. P., Matthaei S., Olefsky J. M. Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest. 1988 May;81(5):1528–1536. doi: 10.1172/JCI113485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gerich J. E. Oral hypoglycemic agents. N Engl J Med. 1989 Nov 2;321(18):1231–1245. doi: 10.1056/NEJM198911023211805. [DOI] [PubMed] [Google Scholar]
  33. Groop L. C., Bonadonna R. C., DelPrato S., Ratheiser K., Zyck K., Ferrannini E., DeFronzo R. A. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989 Jul;84(1):205–213. doi: 10.1172/JCI114142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Guare J. C., Wing R. R., Marcus M. D., Epstein L. H., Burton L. R., Gooding W. E. Analysis of changes in eating behavior and weight loss in type II diabetic patients. Which behaviors to change. Diabetes Care. 1989 Jul-Aug;12(7):500–503. doi: 10.2337/diacare.12.7.500. [DOI] [PubMed] [Google Scholar]
  35. Haffner S. M., Mitchell B. D., Pugh J. A., Stern M. P., Kozlowski M. K., Hazuda H. P., Patterson J. K., Klein R. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care. 1989 Sep;12(8):530–536. doi: 10.2337/diacare.12.8.530. [DOI] [PubMed] [Google Scholar]
  36. Hanenberg H., Kolb-Bachofen V., Kantwerk-Funke G., Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia. 1989 Feb;32(2):126–134. doi: 10.1007/BF00505185. [DOI] [PubMed] [Google Scholar]
  37. Howey J. E., Bennet W. M., Browning M. C., Jung R. T., Fraser C. G. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation. Diabet Med. 1989 Dec;6(9):793–796. doi: 10.1111/j.1464-5491.1989.tb01281.x. [DOI] [PubMed] [Google Scholar]
  38. Jacobson J. D., Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol. 1989 Oct;161(4):981–986. doi: 10.1016/0002-9378(89)90767-9. [DOI] [PubMed] [Google Scholar]
  39. James D. E., Strube M., Mueckler M. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature. 1989 Mar 2;338(6210):83–87. doi: 10.1038/338083a0. [DOI] [PubMed] [Google Scholar]
  40. Jennings A. M., Wilson R. M., Ward J. D. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care. 1989 Mar;12(3):203–208. doi: 10.2337/diacare.12.3.203. [DOI] [PubMed] [Google Scholar]
  41. Jennings P. E., Nightingale S., Le Guen C., Lawson N., Williamson J. R., Hoffman P., Barnett A. H. Prolonged aldose reductase inhibition in chronic peripheral diabetic neuropathy: effects on microangiopathy. Diabet Med. 1990 Jan;7(1):63–68. doi: 10.1111/j.1464-5491.1990.tb01310.x. [DOI] [PubMed] [Google Scholar]
  42. Johnson A. B., Argyraki M., Thow J. C., Broughton D., Jones I. R., Taylor R. Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients. Diabet Med. 1990 Jun;7(5):420–428. doi: 10.1111/j.1464-5491.1990.tb01417.x. [DOI] [PubMed] [Google Scholar]
  43. Johnston C., Alviggi L., Millward B. A., Leslie R. D., Pyke D. A., Vergani D. Alterations in T-lymphocyte subpopulations in type I diabetes. Exploration of genetic influence in identical twins. Diabetes. 1988 Nov;37(11):1484–1488. doi: 10.2337/diab.37.11.1484. [DOI] [PubMed] [Google Scholar]
  44. Jørgensen S., Vaag A., Langkjaer L., Hougaard P., Markussen J. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. BMJ. 1989 Aug 12;299(6696):415–419. doi: 10.1136/bmj.299.6696.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kasanicki M. A., Pilch P. F. Regulation of glucose-transporter function. Diabetes Care. 1990 Mar;13(3):219–227. doi: 10.2337/diacare.13.3.219. [DOI] [PubMed] [Google Scholar]
  46. Kawamori R., Bando K., Yamasaki Y., Kubota M., Watarai T., Iwama N., Shichiri M., Kamada T. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects. Diabetes Care. 1989 Nov-Dec;12(10):680–685. doi: 10.2337/diacare.12.10.680. [DOI] [PubMed] [Google Scholar]
  47. Klip A., Leiter L. A. Cellular mechanism of action of metformin. Diabetes Care. 1990 Jun;13(6):696–704. doi: 10.2337/diacare.13.6.696. [DOI] [PubMed] [Google Scholar]
  48. Langer O., Anyaegbunam A., Brustman L., Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol. 1989 Sep;161(3):593–599. doi: 10.1016/0002-9378(89)90361-x. [DOI] [PubMed] [Google Scholar]
  49. Langer O., Levy J., Brustman L., Anyaegbunam A., Merkatz R., Divon M. Glycemic control in gestational diabetes mellitus--how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol. 1989 Sep;161(3):646–653. doi: 10.1016/0002-9378(89)90371-2. [DOI] [PubMed] [Google Scholar]
  50. Lawrence P. A., Dowe M. C., Perry E. K., Strong S., Samsa G. P. Accuracy of nurses in performing capillary blood glucose monitoring. Diabetes Care. 1989 Apr;12(4):298–301. doi: 10.2337/diacare.12.4.298. [DOI] [PubMed] [Google Scholar]
  51. Levy P. Effects of prazosin on blood pressure and diabetic control in patients with type II diabetes mellitus and mild essential hypertension. Am J Med. 1989 Jan 23;86(1B):59–62. doi: 10.1016/0002-9343(89)90132-0. [DOI] [PubMed] [Google Scholar]
  52. Luzi L., DeFronzo R. A. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol. 1989 Aug;257(2 Pt 1):E241–E246. doi: 10.1152/ajpendo.1989.257.2.E241. [DOI] [PubMed] [Google Scholar]
  53. Magee M. S., Knopp R. H., Benedetti T. J. Metabolic effects of 1200-kcal diet in obese pregnant women with gestational diabetes. Diabetes. 1990 Feb;39(2):234–240. doi: 10.2337/diab.39.2.234. [DOI] [PubMed] [Google Scholar]
  54. Mandrup-Poulsen T., Mølvig J., Andersen H. U., Helqvist S., Spinas G. A., Munck M. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group. Diabetes. 1990 Feb;39(2):204–210. doi: 10.2337/diab.39.2.204. [DOI] [PubMed] [Google Scholar]
  55. Mauer S. M., Goetz F. C., McHugh L. E., Sutherland D. E., Barbosa J., Najarian J. S., Steffes M. W. Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes. 1989 Apr;38(4):516–523. doi: 10.2337/diab.38.4.516. [DOI] [PubMed] [Google Scholar]
  56. Mbanya J. C., Thomas T. H., Taylor R., Alberti K. G., Wilkinson R. Increased proximal tubular sodium reabsorption in hypertensive patients with type 2 diabetes. Diabet Med. 1989 Sep-Oct;6(7):614–620. doi: 10.1111/j.1464-5491.1989.tb01238.x. [DOI] [PubMed] [Google Scholar]
  57. McCance D. R., Hadden D. R., Atkinson A. B., Archer D. B., Kennedy L. Long-term glycaemic control and diabetic retinopathy. Lancet. 1989 Oct 7;2(8667):824–828. doi: 10.1016/s0140-6736(89)92996-6. [DOI] [PubMed] [Google Scholar]
  58. McCulloch D. K., Klaff L. J., Kahn S. E., Schoenfeld S. L., Greenbaum C. J., Mauseth R. S., Benson E. A., Nepom G. T., Shewey L., Palmer J. P. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes. 1990 May;39(5):549–556. doi: 10.2337/diab.39.5.549. [DOI] [PubMed] [Google Scholar]
  59. McMahon M., Marsh H. M., Rizza R. A. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. Diabetes. 1989 Mar;38(3):291–303. doi: 10.2337/diab.38.3.291. [DOI] [PubMed] [Google Scholar]
  60. Mendola G., Casamitjana R., Gomis R. Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia. 1989 Mar;32(3):160–162. doi: 10.1007/BF00265087. [DOI] [PubMed] [Google Scholar]
  61. Mitsukawa T., Takemura J., Asai J., Nakazato M., Kangawa K., Matsuo H., Matsukura S. Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes. 1990 May;39(5):639–642. doi: 10.2337/diab.39.5.639. [DOI] [PubMed] [Google Scholar]
  62. Molina J. M., Cooper G. J., Leighton B., Olefsky J. M. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes. 1990 Feb;39(2):260–265. doi: 10.2337/diab.39.2.260. [DOI] [PubMed] [Google Scholar]
  63. Mueller M. J., Diamond J. E., Sinacore D. R., Delitto A., Blair V. P., 3rd, Drury D. A., Rose S. J. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care. 1989 Jun;12(6):384–388. doi: 10.2337/diacare.12.6.384. [DOI] [PubMed] [Google Scholar]
  64. Nakache R., Tydén G., Groth C. G. Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes. 1989 Jan;38 (Suppl 1):40–42. doi: 10.2337/diab.38.1.s40. [DOI] [PubMed] [Google Scholar]
  65. Nelson R. G., Wolfe J. A., Horton M. B., Pettitt D. J., Bennett P. H., Knowler W. C. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes. 1989 Apr;38(4):435–440. doi: 10.2337/diab.38.4.435. [DOI] [PubMed] [Google Scholar]
  66. Odawara M., Kadowaki T., Yamamoto R., Shibasaki Y., Tobe K., Accili D., Bevins C., Mikami Y., Matsuura N., Akanuma Y. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science. 1989 Jul 7;245(4913):66–68. doi: 10.1126/science.2544998. [DOI] [PubMed] [Google Scholar]
  67. Osei K. Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM. Diabetes. 1990 May;39(5):597–601. doi: 10.2337/diab.39.5.597. [DOI] [PubMed] [Google Scholar]
  68. Parving H. H., Hommel E., Damkjaer Nielsen M., Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BMJ. 1989 Aug 26;299(6698):533–536. doi: 10.1136/bmj.299.6698.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Parving H. H., Hommel E. Prognosis in diabetic nephropathy. BMJ. 1989 Jul 22;299(6693):230–233. doi: 10.1136/bmj.299.6693.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Pedersen O., Bak J. F., Andersen P. H., Lund S., Moller D. E., Flier J. S., Kahn B. B. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 1990 Jul;39(7):865–870. doi: 10.2337/diab.39.7.865. [DOI] [PubMed] [Google Scholar]
  71. Phillipou G., Farrant R. K., Phillips P. J. Computer based quality assessment of hospital capillary blood glucose monitoring. Diabet Med. 1990 Mar-Apr;7(3):234–237. doi: 10.1111/j.1464-5491.1990.tb01376.x. [DOI] [PubMed] [Google Scholar]
  72. Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989 Sep 28;321(13):868–873. doi: 10.1056/NEJM198909283211305. [DOI] [PubMed] [Google Scholar]
  73. Pollare T., Lithell H., Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990 Feb;39(2):167–174. doi: 10.1016/0026-0495(90)90071-j. [DOI] [PubMed] [Google Scholar]
  74. Pollare T., Lithell H., Mörlin C., Präntare H., Hvarfner A., Ljunghall S. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens. 1989 Jul;7(7):551–559. doi: 10.1097/00004872-198907000-00006. [DOI] [PubMed] [Google Scholar]
  75. Pollare T., Lithell H., Selinus I., Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ. 1989 Apr 29;298(6681):1152–1157. doi: 10.1136/bmj.298.6681.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Pozzilli P., Visalli N., Ghirlanda G., Manna R., Andreani D. Nicotinamide increases C-peptide secretion in patients with recent onset type 1 diabetes. Diabet Med. 1989 Sep-Oct;6(7):568–572. doi: 10.1111/j.1464-5491.1989.tb01229.x. [DOI] [PubMed] [Google Scholar]
  77. Ramachandran A., Snehalatha C., Mohan V., Bhattacharyya P. K., Viswanathan M. Decreased insulin sensitivity in offspring whose parents both have type 2 diabetes. Diabet Med. 1990 May;7(4):331–334. doi: 10.1111/j.1464-5491.1990.tb01400.x. [DOI] [PubMed] [Google Scholar]
  78. Ratner R. E., Whitehouse F. W. Motor vehicles, hypoglycemia, and diabetic drivers. Diabetes Care. 1989 Mar;12(3):217–222. doi: 10.2337/diacare.12.3.217. [DOI] [PubMed] [Google Scholar]
  79. Reaven P. D., Barrett-Connor E. L., Browner D. K. Abnormal glucose tolerance and hypertension. Diabetes Care. 1990 Feb;13(2):119–125. doi: 10.2337/diacare.13.2.119. [DOI] [PubMed] [Google Scholar]
  80. Rogers D., Bitner-Glindzicz M., Harris C., Yudkin J. S. Non-mydriatic retinal photography as a screening service for general practitioners. Diabet Med. 1990 Feb;7(2):165–167. doi: 10.1111/j.1464-5491.1990.tb01353.x. [DOI] [PubMed] [Google Scholar]
  81. Scharp D. W., Lacy P. E., Santiago J. V., McCullough C. S., Weide L. G., Falqui L., Marchetti P., Gingerich R. L., Jaffe A. S., Cryer P. E. Insulin independence after islet transplantation into type I diabetic patient. Diabetes. 1990 Apr;39(4):515–518. doi: 10.2337/diab.39.4.515. [DOI] [PubMed] [Google Scholar]
  82. Sheehy M. J., Scharf S. J., Rowe J. R., Neme de Gimenez M. H., Meske L. M., Erlich H. A., Nepom B. S. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest. 1989 Mar;83(3):830–835. doi: 10.1172/JCI113965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Shulman G. I., Rothman D. L., Jue T., Stein P., DeFronzo R. A., Shulman R. G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990 Jan 25;322(4):223–228. doi: 10.1056/NEJM199001253220403. [DOI] [PubMed] [Google Scholar]
  84. Simpson H. C., Sturley R., Stirling C. A., Reckless J. P. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients. Diabet Med. 1990 Feb;7(2):143–147. doi: 10.1111/j.1464-5491.1990.tb01349.x. [DOI] [PubMed] [Google Scholar]
  85. Singer D. E., Moulton A. W., Nathan D. M. Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors. Diabetes. 1989 Mar;38(3):350–357. doi: 10.2337/diab.38.3.350. [DOI] [PubMed] [Google Scholar]
  86. Songer T. J. Drivers with diabetes. Innocent until proven guilty. Diabetes Care. 1989 Mar;12(3):233–234. doi: 10.2337/diacare.12.3.233. [DOI] [PubMed] [Google Scholar]
  87. Southgate D. A. Nibblers, gorgers, snackers, and grazers. BMJ. 1990 Jan 20;300(6718):136–137. doi: 10.1136/bmj.300.6718.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Stancin T., Link D. L., Reuter J. M. Binge eating and purging in young women with IDDM. Diabetes Care. 1989 Oct;12(9):601–603. doi: 10.2337/diacare.12.9.601. [DOI] [PubMed] [Google Scholar]
  89. Stevens A. B., Roberts M., McKane R., Atkinson A. B., Bell P. M., Hayes J. R. Motor vehicle driving among diabetics taking insulin and non-diabetics. BMJ. 1989 Sep 2;299(6699):591–595. doi: 10.1136/bmj.299.6699.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Sutherland D. E., Moudry K. C., Dunn D. L., Goetz F. C., Najarian J. S. Pancreas-transplant outcome in relation to presence or absence of end-stage renal disease, timing of transplant, surgical technique, and donor source. Diabetes. 1989 Jan;38 (Suppl 1):10–12. doi: 10.2337/diab.38.1.s10. [DOI] [PubMed] [Google Scholar]
  91. Taft J. L., Billson V. R., Nankervis A., Kincaid-Smith P., Martin F. I. A clinical-histological study of individuals with diabetes mellitus and proteinuria. Diabet Med. 1990 Mar-Apr;7(3):215–221. doi: 10.1111/j.1464-5491.1990.tb01373.x. [DOI] [PubMed] [Google Scholar]
  92. Taira M., Taira M., Hashimoto N., Shimada F., Suzuki Y., Kanatsuka A., Nakamura F., Ebina Y., Tatibana M., Makino H. Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science. 1989 Jul 7;245(4913):63–66. doi: 10.1126/science.2544997. [DOI] [PubMed] [Google Scholar]
  93. Tattersall R. Is pancreas transplantation for insulin-dependent diabetics worthwhile? N Engl J Med. 1989 Jul 13;321(2):112–114. doi: 10.1056/NEJM198907133210210. [DOI] [PubMed] [Google Scholar]
  94. Taylor S. I., Kadowaki T., Kadowaki H., Accili D., Cama A., McKeon C. Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care. 1990 Mar;13(3):257–279. doi: 10.2337/diacare.13.3.257. [DOI] [PubMed] [Google Scholar]
  95. Temple R. C., Carrington C. A., Luzio S. D., Owens D. R., Schneider A. E., Sobey W. J., Hales C. N. Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1989 Feb 11;1(8633):293–295. doi: 10.1016/s0140-6736(89)91306-8. [DOI] [PubMed] [Google Scholar]
  96. Thies R. S., Molina J. M., Ciaraldi T. P., Freidenberg G. R., Olefsky J. M. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes. 1990 Feb;39(2):250–259. doi: 10.2337/diab.39.2.250. [DOI] [PubMed] [Google Scholar]
  97. Thorens B., Charron M. J., Lodish H. F. Molecular physiology of glucose transporters. Diabetes Care. 1990 Mar;13(3):209–218. doi: 10.2337/diacare.13.3.209. [DOI] [PubMed] [Google Scholar]
  98. Trischitta V., Brunetti A., Chiavetta A., Benzi L., Papa V., Vigneri R. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes. 1989 Dec;38(12):1579–1584. doi: 10.2337/diab.38.12.1579. [DOI] [PubMed] [Google Scholar]
  99. Tunbridge F. K., Newens A., Home P. D., Davis S. N., Murphy M., Burrin J. M., Alberti K. G., Jensen I. A comparison of human ultralente- and lente-based twice-daily injection regimens. Diabet Med. 1989 Aug;6(6):496–501. doi: 10.1111/j.1464-5491.1989.tb01216.x. [DOI] [PubMed] [Google Scholar]
  100. Tunbridge F. K., Newens A., Home P. D., Davis S. N., Murphy M., Burrin J. M., Alberti K. G., Jensen I. Double-blind crossover trial of isophane (NPH)- and lente-based insulin regimens. Diabetes Care. 1989 Feb;12(2):115–119. doi: 10.2337/diacare.12.2.115. [DOI] [PubMed] [Google Scholar]
  101. Vaag A., Handberg A., Lauritzen M., Henriksen J. E., Pedersen K. D., Beck-Nielsen H. Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care. 1990 Jan;13(1):74–76. doi: 10.2337/diacare.13.1.74. [DOI] [PubMed] [Google Scholar]
  102. Vague P., Picq R., Bernal M., Lassmann-Vague V., Vialettes B. Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1989 May;32(5):316–321. doi: 10.1007/BF00265549. [DOI] [PubMed] [Google Scholar]
  103. Veves A., Masson E. A., Fernando D. J., Boulton A. J. Use of experimental padded hosiery to reduce abnormal foot pressures in diabetic neuropathy. Diabetes Care. 1989 Oct;12(9):653–655. doi: 10.2337/diacare.12.9.653. [DOI] [PubMed] [Google Scholar]
  104. Walker M., Fulcher G. R., Catalano C., Petranyi G., Orskov H., Alberti K. G. Physiological levels of plasma non-esterified fatty acids impair forearm glucose uptake in normal man. Clin Sci (Lond) 1990 Aug;79(2):167–174. doi: 10.1042/cs0790167. [DOI] [PubMed] [Google Scholar]
  105. Williams D. R., Munroe C., Hospedales C. J., Greenwood R. H. A three-year evaluation of the quality of diabetes care in the Norwich community care scheme. Diabet Med. 1990 Jan;7(1):74–79. doi: 10.1111/j.1464-5491.1990.tb01312.x. [DOI] [PubMed] [Google Scholar]
  106. Wise J. E., Keim K. S., Huisinga J. L., Willmann P. A. Effect of sucrose-containing snacks on blood glucose control. Diabetes Care. 1989 Jun;12(6):423–426. doi: 10.2337/diacare.12.6.423. [DOI] [PubMed] [Google Scholar]
  107. Zancanaro C., Cigolini M., Bonora E., Moghetti P., Querena M., Muggeo M. Glucose and insulin suppression of plasma free fatty acids in obese subjects with normal glucose tolerance or mild, newly diagnosed type 2 (non-insulin-dependent) diabetes. J Endocrinol Invest. 1990 Jan;13(1):55–59. doi: 10.1007/BF03348582. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES